The mission of the Type 1 Diabetes (T1D) Center at the La Jolla Institute for Allergy & Immunology is to accelerate the path to find a safe prevention and cure for type 1 diabetes. The Center strives to combine the in-house multidisciplinary expertise in immunology and development of immunotherapies with cutting edge approaches in beta cell regeneration and replacement and local clinical centers. Therefore, close ties with the Brehm Coalition, the Pediatric Diabetes Research Center (PDRC) of San Diego, and the Sanford Foundation have been established. These collaborations are united by their dedication to fighting type 1 diabetes and helping those who suffer from it, and ultimately, all who are touched by the disease.
Cure for Type 1 Diabetes
Day by day, Center Director Matthias von Herrath, M.D., and his lab are edging closer to a goal that has eluded the scientific community for nearly a century—a cure for type 1 diabetes. Von Herrath and his fellow researchers' development of a combination therapy is showing significant promise in type 1 diabetes when caught in the early stages. Work on this promising research continues, with clinical testing currently under way on each of the combination therapy components individually. If required government approvals are received, human clinical trials of the combination therapy are planned.